Dr. Melissa Putman, Assistant Professor at Harvard Medical School and an endocrinologist at Boston Children’s Hospital (BCH) and Massachusetts General Hospital (MGH), gives a comprehensive overview on the connection between cystic fibrosis and bone disease, and the various risk factors contributing to compromised bone health. She also discusses prevention and treatment options, as well as the impact of CFTR modulators on bone health. This presentation was part of CFRI's Virtual 35th National CF Education Conference.
CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.